z-logo
open-access-imgOpen Access
A Targeted Approach for Congenital Cytomegalovirus Screening Within Newborn Hearing Screening
Author(s) -
Karen B. Fowler,
Faye P. McCollister,
Diane L. Sabo,
Angela G. Shoup,
Kris E. Owen,
Julie L. Woodruff,
Edith Cox,
Lisa S. Mohamed,
Daniel Choo,
Suresh B. Boppana
Publication year - 2017
Publication title -
pediatrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.611
H-Index - 345
eISSN - 1098-4275
pISSN - 0031-4005
DOI - 10.1542/peds.2016-2128
Subject(s) - medicine , cytomegalovirus , sensorineural hearing loss , pediatrics , hearing loss , newborn screening , cohort , audiology , human immunodeficiency virus (hiv) , viral disease , herpesviridae , virology
Congenital cytomegalovirus (cCMV) infection remains a leading cause of childhood hearing loss. Currently universal CMV screening at birth does not exist in the United States. An alternative approach could be testing infants who do not pass their newborn hearing screening (NHS) for cCMV. This study was undertaken to evaluate whether a targeted approach will identify infants with CMV-related sensorineural hearing loss (SNHL).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom